The post What Are The Chances Of Ethereum Price Recovery To $2,500 appeared on BitcoinEthereumNews.com. Ethereum has shown early signs of recovery after a prolongedThe post What Are The Chances Of Ethereum Price Recovery To $2,500 appeared on BitcoinEthereumNews.com. Ethereum has shown early signs of recovery after a prolonged

What Are The Chances Of Ethereum Price Recovery To $2,500

Ethereum has shown early signs of recovery after a prolonged period of weakness that pushed prices sharply lower. ETH has attempted to stabilize near key support levels, but further upside depends on sustained backing from investors and broader market conditions. 

At present, Ethereum appears to have at least one of these factors working in its favor, keeping recovery prospects alive.

Sponsored

Sponsored

Ethereum Investors Change Stance

On-chain data suggests a notable shift in investor behavior. The exchange net position change indicator, which tracks capital flows into and out of exchanges, has turned negative for Ethereum. This signals that more ETH is leaving exchanges than entering them, a pattern typically associated with accumulation rather than distribution.

Such outflows suggest holders are choosing to buy and move ETH into private wallets instead of preparing to sell. Lower prices often encourage this behavior as investors position for potential rebounds. This shift in stance reflects improving confidence, even as the price has yet to fully reflect rising demand.

Want more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.

Ethereum Exchange Net Position Change. Source: Glassnode

Broader momentum indicators support this narrative. The Chaikin Money Flow has shown a steady uptick over the past week, reinforcing the trend observed in exchange data. Rising CMF values indicate declining outflows and improving capital flow dynamics across Ethereum markets.

Sponsored

Sponsored

A move above the zero line would mark inflows overtaking outflows, a bullish development for ETH. At the same time, Ethereum has managed to hold above the 23.6% Fibonacci retracement near $2,054. Maintaining this level often acts as a trigger for renewed participation, encouraging investors to deploy capital as downside risk appears more contained.

Ethereum CMF. Source: TradingView

What Is ETH Price’s Next Target?

Ethereum is trading near $2,018 at the time of writing, signaling that demand remains present beneath current prices. The challenge lies in translating that demand into sustained upward movement. A successful bounce from the $2,000 level could push ETH through $2,205, a key short-term resistance. Beyond that, the psychological target of $2,500 comes into focus.

Ethereum Price Analysis. Source: TradingView

Reaching $2,500 may not prove difficult from a structural standpoint. Cost basis distribution data shows relatively light accumulation around this zone, suggesting limited overhead supply. As a result, ETH could move through this range with less resistance once momentum builds. Stronger accumulation clusters appear closer to $2,800, which is likely to act as a more meaningful barrier.

Ethereum CBD Heatmap. Source: Glassnode

Before that scenario plays out, Ethereum must clear intermediate hurdles. A decisive move above $2,344 would confirm recovery strength and validate the path toward $2,500 and potentially higher levels. Failure to sustain current support, however, would undermine the bullish setup. A loss of the $2,000 level would expose ETH to renewed downside risk, with $1,796 emerging as the next major support area.

Source: https://beincrypto.com/ethereum-price-looks-primed-to-bounce/

Market Opportunity
Ethereum Logo
Ethereum Price(ETH)
$2,017.7
$2,017.7$2,017.7
-0.24%
USD
Ethereum (ETH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

The Silver Price Doesn’t Look Real – And This Video Explains Why

The Silver Price Doesn’t Look Real – And This Video Explains Why

The Silver (XAG) price has been acting strange lately. Just when it looked like the market was settling down, a new argument started spreading fast: silver might
Share
Captainaltcoin2026/02/11 04:00
Will XRP Price Increase In September 2025?

Will XRP Price Increase In September 2025?

Ripple XRP is a cryptocurrency that primarily focuses on building a decentralised payments network to facilitate low-cost and cross-border transactions. It’s a native digital currency of the Ripple network, which works as a blockchain called the XRP Ledger (XRPL). It utilised a shared, distributed ledger to track account balances and transactions. What Do XRP Charts Reveal? […]
Share
Tronweekly2025/09/18 00:00
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11